Home
Acandis

Acandis Market Share Analysis for August 2026

Acandis Datenschutz: Der Schutz der persönlichen Daten der Besucher unserer Website ist uns ein zentrales Anliegen.

Industry: N/A

Domainacandis.com

Year Founded2006

Employees201 - 500

Annual Revenue$5M - $10M

Acandis

Acandis (including company regionals)

acandis.com

See more website traffic and engagement information

Acandis Revenue up to August 2026 is 5M - 10M

revenue generated by Acandis top domains

Acandis top domains revenue over 3 years

Revenue for Acandis top domains

acandis.com5M - 10M

See more with Sales Intelligence

Total visits to Acandis's top domains

Understand Acandis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

acandis.com5.8K

See more with Sales Intelligence

Avg. visit duration in Acandis's top domains

Analyze Acandis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

acandis.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Acandis's top domains

See how Acandis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

acandis.com1.76

See more with Sales Intelligence

Acandis top competitors by domain

Top similar sites in August 2026, ranked by their affinity

nevro.comCompany NameNevroEmployees1001 - 5000HQUnited States, California, Redwood CityAnnual revenue$200M - $500MTotal visits10.8KHealth > Health - Other

Top technologies used by Acandis

These are the website technologies, by industry, used by Acandis top domains

Widget (4)

Twemoji

Conversion & Analytics (3)

Matomo (Previously Piwik)

Advertising (1)

PubMatic

Audio Video Media (1)

YouTube

More Technologies

7

See all

News & Signals from Acandis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAcandis GmbH launched Accero Rex stent on Jul 1st '26.Additionally, earlier this month, Acandis announced the launch of the Accero Rex stent in Brazil, stating that this marks an important milestone that will enable additional treatment options for intracranial aneurysms.

NewsLauxera Capital Partners invests into Acandis GmbH $52.3M.Lauxera invests €50m in Acandis, a German, neurovascular medical device company dedicated to the prevention and treatment of stroke.